• Recombinant Annexin V: Advancing Apoptotic Membrane Detectio

  2026-08-04

  The reference study details a robust protocol for expressing and purifying recombinant, polyhistidine-tagged annexin V in Escherichia coli, enabling sensitive and reproducible detection of apoptotic cells by targeting phosphatidylserine externalization. This methodological advance streamlines apoptosis quantification in cell biology and gastrointestinal research, facilitating high-yield annexin V production and reliable flow cytometry or fluorescence microscopy assays.

• Structure-Guided Proteomimetics Disrupt SARS-CoV-2 S-RBD/hAC

  2026-08-04

  This article examines the rational design of constrained proteomimetics that selectively disrupt the challenging SARS-CoV-2 Spike RBD/hACE2 protein–protein interaction. The study demonstrates how structure-guided peptide engineering can yield high-specificity antiviral inhibitors, setting a new precedent for targeting complex viral-host interfaces.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Interactio

  2026-08-03

  The referenced study reveals that naturally occurring angiotensin peptides, including Angiotensin 1/2 (1-6), significantly enhance the binding of the SARS-CoV-2 spike protein to the host receptor AXL. These findings bridge cardiovascular peptide signaling and viral entry pathways, offering new insight into COVID-19 pathogenesis and experimental modeling.

• Tolazoline as an α2-Adrenergic Receptor Antagonist: Lab Work

  2026-08-03

  Tolazoline stands out as a dual-action tool for dissecting α2-adrenergic receptor pathways and modulating insulin secretion in both airway and islet function assays. This article details practical, literature-backed protocols, showcases recent advances in receptor binding assessment, and provides troubleshooting strategies for reproducible, high-impact results.

• Perineuronal Net Degradation Drives Social Memory Loss in AD

  2026-08-02

  This study reveals that loss of perineuronal nets (PNNs) in the hippocampal CA2 region triggers social cognition deficits in a mouse model of Alzheimer’s disease. Chronic inhibition of matrix metalloproteinases (MMPs) preserves PNNs and delays social memory loss, providing mechanistic insight and highlighting extracellular matrix remodeling as a therapeutic target.

• 5-Methyl-CTP in mRNA Synthesis: Elevating Stability & Effici

  2026-08-01

  5-Methyl-CTP empowers mRNA synthesis workflows with enhanced stability and translation efficiency, making it indispensable for advanced vaccine and therapeutic development. This guide bridges bench experience and recent animal model breakthroughs to help researchers optimize their protocols and troubleshoot common pitfalls.

• EPZ-6438: EZH2 Inhibitor Workflows in Epigenetic Cancer Rese

  2026-07-31

  EPZ-6438 enables precise interrogation of the PRC2 pathway, supporting breakthrough workflows in HPV-driven and other EZH2-dependent cancer models. This guide translates bench research and clinical insights into actionable steps for maximizing assay performance and troubleshooting.

• Substance P in Translational Pain and Inflammation Research

  2026-07-31

  Substance P enables precise modeling of pain, inflammation, and immune response pathways, with high purity and solubility supporting reproducible CNS research. Integrating advanced spectral analytics, as demonstrated in recent machine-learning studies, further elevates its utility in complex experimental workflows.

• Dabigatran for Research: Mechanistic Precision and Assay Inn

  2026-07-30

  Explore the unique pharmacological profile and advanced research applications of Dabigatran, a leading direct thrombin inhibitor. This article delivers new scientific insights for assay design, protocol optimization, and practical use, setting it apart from existing content.

• Cyclophosphamide: Protocol Enhancements for Cancer Research

  2026-07-30

  Cyclophosphamide stands out as a versatile alkylating chemotherapeutic agent, enabling precise apoptosis induction and immune modulation in both cancer and autoimmune models. This article delivers evidence-based workflow refinements, troubleshooting strategies, and actionable insights to help scientists maximize reproducibility and translational impact using APExBIO’s Cyclophosphamide.

• Nadolol (SQ-11725): Mechanism, Evidence & Research Integrati

  2026-07-29

  Nadolol (SQ-11725) is a non-selective, orally active beta-adrenergic receptor blocker widely used in cardiovascular research. Its utility spans hypertension, angina pectoris, and vascular headache studies, with robust evidence for transporter-influenced pharmacokinetics. This dossier details its biological basis, mechanism, and laboratory applications with verified benchmarks and protocol parameters.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Optimizing Dual-Fluorescenc

  2026-07-29

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) enables real-time tracking of both mRNA uptake and protein translation, streamlining gene delivery optimization. Its advanced Cap 1 structure and dual-label design empower reliable quantitative assays and high-sensitivity imaging for next-generation mRNA therapeutics.

• Isorhamnetin in Cellular Stress and Oocyte Quality: Novel Pa

  2026-07-28

  Explore the multifaceted role of Isorhamnetin in modulating cellular stress and enhancing oocyte quality via MAPK and PI3K/Akt pathways. This in-depth analysis reveals new mechanistic insights and advanced applications for researchers.

• Carboxylesterase Interference in Amplex Red-Based Mitochondr

  2026-07-28

  Miwa et al. reveal that carboxylesterases can directly convert Amplex Red to resorufin, independent of hydrogen peroxide and peroxidase, distorting mitochondrial ROS measurements. This finding prompts a critical re-evaluation of Amplex Red-based H2O2 assays and offers corrective strategies for researchers.

• Distinct Roles of ERK5 and ERK1/2 in AML Differentiation Ind

  2026-07-27

  This study defines the differential contributions of ERK5 and ERK1/2 MAPK pathways in mediating terminal differentiation and cell cycle arrest of acute myeloid leukemia (AML) cells in response to 1α,25-dihydroxyvitamin D3. The findings suggest that selective modulation of these pathways could optimize differentiation-based therapies for AML, informing both experimental design and potential translational approaches.

15768 records 1/1052 page Next 12345 下5页 Last page